Providing minimally invasive
cryogenic solutions for safer lung
disease diagnosis and therapy

Endocision is bronchoscopy made cool.

The next generation in
transbronchial lung cryobiopsy

The best way to diagnose Interstitial Lung Disease today involves a visit
to the operating room, and carries risks of severe or fatal complications

4M

new cases of interstitial lung diseases every year globally, but the majority remains undiagnosed

6%

mortality risk with surgical lung biopsy, the gold standard to obtain a precise diagnosis

1 in 10

bronchoscopic cryobiopsies today have severe complications such as bleeding

We developed a better way.

Endocision's innovative cryobiopsy platform enables safer, effective, and
cost-effective lung biopsy and will expand access to lung disease diagnosis.

  • Simplified management of complications
  • No loss of positioning or visualization
  • No capital equipment requirement
  • Single-user procedure
  • Comparable tissue samples as standard practice
  • Compatible with robotic bronchoscopes

See how we compare

Our testing shows that Endocision's device produces samples
that are comparable to current standard.

Get to know us

Moishe Liberman

Moishe Liberman

President & Chief Medical Officer

Marc Chelala

Marc Chelala

Chief Operating Officer

 

Anthony Sirgi

Anthony Sirgi

QARA Director

 

Bruno Chabot

Bruno Chabot

Principal R&D Specialist

 

Diya Tannani

Diya Tannani

QARA Specialist

 

Our Scientific Advisory Board

Felix Herth

Felix Herth

Thoraxklinik, Heidelberg, GER

Lonny Yarmus

Lonny Yarmus

Johns Hopkins Hospital, Baltimore, USA

Kazuhiro Yasufuku

Kazuhiro Yasufuku

University Health Network, Toronto, CAN

Momen Wahidi

Momen Wahidi

Northwestern Memorial Hospital, Chicago, USA

Careers

Want to join our team? Keep an eye out for our openings below.

  • Job Title
    Department
  • Product Development Engineer

    R&D (Montréal, QC)

    Find out more

Visit our LinkedIn and Indeed pages for updates on openings

Easy Applyindeed

Newsroom

A human, ex-vivo, diseased lung clinical trial with Endocision cryobiopsy probe

The Endocision cryobiopsy probe was amongst devices tested in a study to define optimal settings for lung cryobiopsy

Endocision joins MedTech Innovator 2023 cohort, world’s largest medtech accelerator program

Now in its 11th year, MedTech Innovator continues to identify the best medical device, diagnostic and digital health startups developing innovative tools to improve patient care

Endocision closes seed financing round to support regulatory clearance of its cryocatheter platform

Funding supports Endocision’s mission to bring safe and effective devices for lung disease diagnosis and treatment

Our Partners